Skip to content

HEATHCARE BRIEFING

Primary Menu
  • Home
  • Medical Research & Innovation
  • AI in Health
  • Healthcare News
  • Digital Health & Technology
  • Pharma & Biotech
Light/Dark Button
  • Home
  • Gene therapy

Gene therapy

Ultragenyx Rare Disease Voucher Sales Secure $413M for More Potential Pipeline Building ultragenyx-rare-disease-voucher-sales-secure-$413m-for-more-potential-pipeline-building

Ultragenyx Rare Disease Voucher Sales Secure $413M for More Potential Pipeline Building

admin Posted on 1 day ago
Ultragenyx recently received two separate FDA approvals for gene therapies in the span of a month, each...
Read More Read more about Ultragenyx Rare Disease Voucher Sales Secure $413M for More Potential Pipeline Building
STAT+: Life Biosciences share glaucoma study updates for its cellular reprogramming drug stat+:-life-biosciences-share-glaucoma-study-updates-for-its-cellular-reprogramming-drug

STAT+: Life Biosciences share glaucoma study updates for its cellular reprogramming drug

admin Posted on 7 days ago
NIH funding uncertainty thwarts U.S. researchers, Argenx stumbles, and more biotech news Adobe Jason is a general...
Read More Read more about STAT+: Life Biosciences share glaucoma study updates for its cellular reprogramming drug
  • Privacy Policy
  • Terms and Conditions
  • Contact